Cargando…
A targeted therapy for melanoma by graphene oxide composite with microRNA carrier
BACKGROUND: Nowadays, the combination of microRNA (miR) is attracting increased attention in clinical cancer trials. However, the clinical use of miR is highly limited because of certain properties such as instability, low-specificity distribution, and metabolic toxicity. METHODS: In order to improv...
Autores principales: | Liu, Can, Xie, Huiqing, Yu, Jingang, Chen, Xiaoqing, Tang, Shijie, Sun, Lichun, Chen, Xiang, Peng, Defei, Zhang, Xiangyan, Zhou, Jianda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157538/ https://www.ncbi.nlm.nih.gov/pubmed/30275686 http://dx.doi.org/10.2147/DDDT.S160088 |
Ejemplares similares
-
Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354
por: Liu, Can, et al.
Publicado: (2019) -
microRNA-33a-5p increases radiosensitivity by inhibiting glycolysis in melanoma
por: Cao, Ke, et al.
Publicado: (2017) -
MicroRNA-18b inhibits the growth of malignant melanoma via inhibition of HIF-1α-mediated glycolysis
por: Chen, Yao, et al.
Publicado: (2021) -
Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB
por: Xie, Biao, et al.
Publicado: (2016) -
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
por: Wang, Hairong, et al.
Publicado: (2018)